Mumme Marcus, Wixmerten Anke, Miot Sylvie, Barbero Andrea, Kaempfen Alexandre, Saxer Franziska, Gehmert Sebastian, Krieg Andreas, Schaefer Dirk J., Jakob Marcel, Martin Ivan

Tissue engineering for paediatric patients

Swiss Med Wkly. 2019;149:w20032

Tissue engineering approaches in a paediatric population are particularly relevant because of the critical need for transplant material and the small amount of accessible autologous graft tissue.

Tatsidou Evanthia, Tsiamis Costas, Karamagioli Evika, Boudouris Georgios, Pikoulis Andreas, Kakalou Eleni, Pikoulis Emmanuel

Reflecting upon the humanitarian use of unmanned aerial vehicles (drones)

Swiss Med Wkly. 2019;149:w20065

Hopes are very high that drones will provide extraordinary help to emergency response teams. On the other hand, critics are concerned about the real value of this technology.

Wang Sophie S., Yang Yang, Velz Julia, Keller Emanuela, Luft Andreas R., Regli Luca, Neidert Marian C., Bozinov Oliver

Management of brainstem haemorrhages

Swiss Med Wkly. 2019;149:w20062

Primary brainstem haemorrhages remain associated with poor outcomes compared to other forms of spontaneous intracranial haemorrhage. Their management needs re-evaluation and reinvestigation to update the relevant data.

Mery Benoîte, Vallard Alexis, Rowinski Elise, Magne Nicolas

High-throughput sequencing in clinical oncology: from past to present

Swiss Med Wkly. 2019;149:w20057

Major improvements in biotechnology and bioinformatics have been achieved over the past two decades, allowing the development of omic signatures of several molecular subtypes of cancer, each associated with different outcomes.

Samaras Panagiotis, Bargetzi Mario, Betticher Daniel C., Driessen Christoph, Duchosal Michel A., Heim Dominik, Ketterer Nicolas, Lerch Erika, Matthes Thomas, Mey Ulrich, Pabst Thomas, Schmidt Adrian, Taverna Christian, Zander Thilo, Renner Christoph

Updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland

Swiss Med Wkly. 2019;149:w20031

The recent increase in knowledge about multiple myeloma necessitated an update of the guidelines published 3 years ago.

Da Costa-Demaurex Claire, Cárdenas Maria T., Aparicio Hernando, Bodenmann Patrick, Genton Blaise, D’Acremont Valérie

Screening strategy for Chagas disease in a non-endemic country (Switzerland): a prospective evaluation

Swiss Med Wkly. 2019;149:w20050

Knowledge of the positive predictors for Chagas disease is important to better target screening for the highest risk population. Another important element in the design of an effective screening strategy is the type of diagnostic test to be used.

Compagno Francesca, Naegele Klaudia, Kahlert Christian R., Hösli Irene, Aebi-Popp Karoline, Martinez de Tejada Begona, Paioni Paolo, Yerly Sabine, Böni Jürg, Battegay Manuel, Rudin Christoph, Hirsch Hans H., the Swiss HIV Cohort Study

The rate of mother-to-child transmission of antiretroviral drug-resistant HIV strains is low in the Swiss Mother and Child HIV Cohort Study

Swiss Med Wkly. 2019;149:w20059

Combination anti-retroviral therapy (cART) has reduced mother-to-child transmission (MTCT) and improved the prognosis of HIV-infected newborns. However, drug resistance mutations (DRM) either transmitted by MTCT (HIV-tDRM) or selected by suboptimal adherence and drug levels (HIV-sDRM) remain a concern.

Erratum to: Clinical characteristics, audiological and neurodevelopmental outcomes of newborns with congenital cytomegalovirus infection

Swiss Med Wkly. 2019;149:w20075

Erratum to: Molecular imaging for neuroendeocrine tumours

Swiss Med Wkly. 2019;149:w20076